These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12680332)

  • 1. [Comparison of incidence of BPH and related factors between urban and rural inhabitants in district of Wannan].
    Zhang SX; Yu B; Guo SL; Wang YW; Yin CK
    Zhonghua Nan Ke Xue; 2003 Feb; 9(1):45-7. PubMed ID: 12680332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the prevalence of benign prostatic hyperplasia in China.
    Gu F
    Chin Med J (Engl); 1997 Mar; 110(3):163-6. PubMed ID: 9594331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A survey of the long-term incidence rate of benign prostate hyperplasia after vasectomy].
    Nie Y; Guo XK; Gao WY; Zhang Y; Li WL; Cheng QX; Bian J; Wang Y; Zhou CG; Cheng SP
    Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1303-5. PubMed ID: 12930682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A comparative study on different doses of cernilton for preventing the clinical progression of benign prostatic hyperplasia].
    Xu J; Qian WQ; Song JD
    Zhonghua Nan Ke Xue; 2008 Jun; 14(6):533-7. PubMed ID: 18649754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The incidences of benign prostatic hyperplasia and prostatic cancer in China].
    Gu FL
    Zhonghua Wai Ke Za Zhi; 1993 Jun; 31(6):323-6. PubMed ID: 7508844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological survey of benign prostatic hyperplasia and prostatic cancer in China.
    Gu F
    Chin Med J (Engl); 2000 Apr; 113(4):299-302. PubMed ID: 11775222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case-control study on the risk factors of benign prostatic hyperplasia in the suburb of Shenyang].
    Ning X; Shi JP; Wu ZY; Zheng LG; Wang HL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Apr; 24(4):276-80. PubMed ID: 12820944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical effectiveness and safety study of combined therapy with an alpha-blocker and an anticholinergic for patients with LUT/BPH].
    Xiao H; Li HZ; Yang Y; Huang ZM; Li YQ; Zhao XF
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1590-3. PubMed ID: 17803845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alfuzosin 10 mg once daily prevents overall clinical progression of benign prostatic hyperplasia but not acute urinary retention: results of a 2-year placebo-controlled study.
    Roehrborn CG
    BJU Int; 2006 Apr; 97(4):734-41. PubMed ID: 16536764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary patterns and surgically treated benign prostatic hyperplasia: a case control study in Western Australia.
    Ambrosini GL; de Klerk NH; Mackerras D; Leavy J; Fritschi L
    BJU Int; 2008 Apr; 101(7):853-60. PubMed ID: 18070188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental research on spontaneous benign prostatic hyperplasia in old dogs].
    Cai RF; Cui YG; Hua LX; Jia Y; Ma DZ; Wang XH
    Zhonghua Nan Ke Xue; 2003 Dec; 9(9):651-3, 657. PubMed ID: 14727348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of the diagnostic criteria of bladder outlet obstruction in benign prostatic hyperplasia].
    Shuang W; Wang D; Zhang X; Liu C; Cao X; Wang J; Gao J; Ren Z; Lü Y
    Zhonghua Nan Ke Xue; 2004 Oct; 10(10):743-6. PubMed ID: 15562786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A population based study of incidence and treatment of benign prostatic hyperplasia among residents of Olmsted County, Minnesota: 1987 to 1997.
    Sarma AV; Jacobson DJ; McGree ME; Roberts RO; Lieber MM; Jacobsen SJ
    J Urol; 2005 Jun; 173(6):2048-53. PubMed ID: 15879823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence of prostatic hyperplasia and its relative factors in six cities of China in 1997].
    Yu P; Zheng H; Su H; Zuo T; Duan C; Gao F; Wang J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Aug; 21(4):276-9. PubMed ID: 11860799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between serum testosterone and measures of benign prostatic hyperplasia in aging men.
    Liu CC; Huang SP; Li WM; Wang CJ; Chou YH; Li CC; Huang CH; Wu WJ
    Urology; 2007 Oct; 70(4):677-80. PubMed ID: 17991536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change in International Prostate Symptom Score, prostrate-specific antigen and prostate volume in patients with benign prostatic hyperplasia followed longitudinally.
    Tsukamoto T; Masumori N; Rahman M; Crane MM
    Int J Urol; 2007 Apr; 14(4):321-4; discussion 325. PubMed ID: 17470162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Data analysis of the objective observation parameters of benign prostatic hyperplasia patients accepting different treatment regimens].
    Zhang YG; Wang JY; Liu M; Wan B; Wei D; Deng SM; Xu J; Wu JY; Chu X; Zeng P
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(24):1690-2. PubMed ID: 19024540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective study.
    Yang Y; Zhao XF; Li HZ; Wang W; Zhang Y; Xiao H; Zhang X
    Chin Med J (Engl); 2007 Mar; 120(5):370-4. PubMed ID: 17376305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A clinical analysis of benign prostatic hyperplasia with chronic prostatitis].
    Wu XJ; Yang LY; Zhang XZ
    Zhonghua Nan Ke Xue; 2008 Jun; 14(6):527-9. PubMed ID: 18649752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dietary survey and biochemical study of blood and urine among Yi and Han nationality farmers in low prevalent district of hypertension].
    Zhang MX
    Zhonghua Liu Xing Bing Xue Za Zhi; 1989 Oct; 10(5):265-9. PubMed ID: 2611867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.